TOPIC: Innovative Health Financing in Developing Markets
SYNOPSIS OF THE TALK:
The World Health Organisation (WHO) estimates that over 100 million people are left impoverished annually due to out-of-pocket healthcare spending. Health shocks are a common cause of financial distress. Thus, it is not a surprise that dramatically increased economic productivity has been closely associated with positive healthcare outcomes. This points to a need to recognize that access to affordable healthcare is a great social as well as economic need.
Availability of healthcare financing is a necessary pre-requisite for affordable access to healthcare. This makes innovative financing in the healthcare sector an urgent societal need. This innovation is taking shape through the introduction of various financial tools and blended capital sources.
Join us as we explore policies and case studies around innovative financing tools that will play a significant role in achieving health equity and economic growth in Asia.
1) Dr. Tim Evans, Director, Health Nutrition & Population, The World Bank
2) Mr. Robert Kraybill, Managing Director, Impact Investment Exchange (Asia)
When: Wednesday, 18 September 2013, 5:30-6:30pm
Where: Seminar Room 3-1,
Level 3, Manasseh Meyer,
Lee Kuan Yew School of Public Policy
469C Bukit Timah Road,
View on Google Maps: http://bit.ly/XbNWfI
ABOUT THE SPEAKERS:
Dr. Tim Evans is the Director for Health, Nutrition and Population at the World Bank. Dr. Evans has been active in the international health arena for more than 20 years.
Before joining the World Bank, Dr. Evans was the Dean of the James P. Grant School of Public Health of BRAC University in Bangladesh. Previously, he served as Assistant Director General at the World Health Organization, heading the Evidence, Information, Research and Policy Clusters. Dr. Evans has been a leader in advancing global health equity and health systems performance throughout his career, notably through his work with the Rockefeller Foundation and the Harvard School of Public Health and with his contributions to the development of innovative partnerships, including the Global Alliance on Vaccines and Immunization, INDEPTH and Health Metrics networks, the Global Health Workforce Alliance and the World Alliance for Patient Safety.
Dr. Evans earned his DPhil in agricultural economics at Oxford, and pursued medical and postgraduate studies at McMaster and Harvard Universities.
Mr Robert Kraybill is Managing Director of IIX, and Treasurer and member of the Board of Shujog. Over the past four years, he has been playing a leadership role in developing the impact investing space in Asia. Mr. Kraybill has over two decades of experience as an investment banker and a private equity investor. He also has significant experience in emerging markets in Asia, having come to the region as regional head of investment banking for Dresdner Kleinworth Wasserstein. More recently, Mr. Kraybill was head of Asian private equity for Marathon Asset Management.
In addition to his work at IIX and Shujog, Mr. Kraybill also acts as Senior Advisor to Asian Tiger Capital, a financial services boutique operating in Bangladesh. Mr. Kraybill has also served as an Adjunct Professor in the MBA program of Singapore Management University.
Mr. Kraybill holds a BA from Princeton University, magna cum laude, and a JD from the University of Pennsylvania School of Law, summa cum laude.